We are dedicated to advancing health around the world.
As a leader in the field of global health, we seek ways to use our business expertise and global footprint to ensure access needs are met around the world. We remain focused on re-defining the treatment paradigm for infectious diseases affecting global communities, most notably including diseases like tuberculosis (TB) and Ebola. We are one of the few innovative healthcare companies in the world today that is actively engaged across multiple disease areas that are central to pandemic preparedness and response.
Despite being preventable and curable, TB is the world’s deadliest infectious disease and one of the top 10 causes of death worldwide. Each year, approximately 1.6 million people die from TB—more than HIV/AIDS and malaria combined.1
For nearly 20 years, Janssen has been supporting global efforts to end TB and combat antimicrobial resistance - both in our laboratories and on the ground in countries impacted by TB and multidrug-resistant tuberculosis (MDR-TB).
Ebola Virus Disease (EVD), formerly known as Ebola haemorrhagic fever, is a rare but severe, often fatal illness in humans.2 The average Ebola case fatality rate is around 50%.2
In response to the Ebola outbreak in West Africa in 2014-16, with the support of global partners, Johnson & Johnson committed to accelerate the development of a preventive Ebola vaccine regimen.
In 2020, as a result of multiple global partnerships, the European Commission (EC) approved our Ebola vaccine regimen for the prevention of Ebola Virus Disease. We are now working to accelerate registration of the vaccine regimen in African countries and facilitate border access to those most in need.
- 5 Latest Facts About Johnson & Johnson's Ebola Vaccine
- Johnson & Johnson’s Commitment to Ebola
- Combating Ebola: How a Johnson & Johnson Vaccine Is Helping in the Fight
- Ebola: The Fight Continues Four Years After the Worst Outbreak in History
1 World Health Organization. Tuberculosis. Available at: https://www.who.int/news-room/fact-sheets/detail/tuberculosis. Last accessed: November 2019.
2 World Health Organization. Ebola virus disease. Available at: https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease. Last accessed: November 2019.